pharmaphorum

FEBRUARY 28, 2022

Amryt has indicated in the past that Oleogel-S10 (formerly AP101) has the potential to become a $1 billion product if approved in the US and Europe. It will take some comfort from fact that it already sells three rare disease therapies and is predicting full-year 2021 sales of $220 to $225 million.

Drugs 98

Drugs Marketing Regulation FDA Approval 98

XTalks

DECEMBER 20, 2023

And this year Eli Lilly stepped into the obesity drug market with its own GLP-1 weight loss drug Zepbound (tirzepatide), which the US Food and Drug Administration (FDA) approved in November of this year. Check out this article to learn about the biotech companies that went public this year.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

OCTOBER 28, 2020

Pfizer could be just a few months away from getting FDA approval for its JAK1 inhibitor abrocitinib in atopic dermatitis, a drug that CEO Albert Bourla believes hasn’t been given the credit it is due by Wall Street analysts.

Drugs 52

Drugs Sales Marketing FDA Approval 52

The Pharma Data

AUGUST 3, 2021

Product sales increased 3% globally, driven by double digit volume growth across a number of our products including Prolia ® (denosumab), Repatha ® (evolocumab) and our biosimilar products MVASI ® (bevacizumab-awwb) and KANJINTI ® (trastuzumab-anns). Product Sales Performance. Key results include: Total revenues increased 5% to $6.5

Sales 52

Sales Production Antibody Development 52

pharmaphorum

SEPTEMBER 22, 2021

However, despite being used on the skin rather than administered systemically, Opzelura has been unable to sidestep the FDA’s class-wide warnings on safety, getting boxed warning for serious infections and an increased risk of heart attack, stroke or cardiac death.

Sales 52

Sales Regulation FDA Approval Marketing 52

The Pharma Data

OCTOBER 9, 2021

Currently there are no FDA-approved treatments for EoE. Under the amended agreement in North America, Amgen and AstraZeneca will jointly commercialise tezepelumab; Amgen will record sales in the US and AstraZeneca will record sales in Canada. Patients are often treated with corticosteroids to manage inflammation.

Drugs 52

Drugs Sales Medicine Dermatology 52

pharmaphorum

JANUARY 5, 2021

An IQVIA survey to Neurology, Cardiology, Rheumatology, Dermatology and Ophthalmologists in June 2020 across the lead five European countries showed an average of 30% of patients either “no shows” or still waiting for treatment that was delayed. Price and value battleground.

Sales 105

Sales Marketing Production Vaccination 105

The Pharma Data

APRIL 26, 2021

Q1 net sales declined -2% (cc¹, +1% USD), due to prior year COVID-19 related forward purchasing (approximately USD 0.4 Kesimpta sales reached USD 50 million. Adakveo sales reached USD 37 million. Sandoz sales declined -13% (cc, -9% USD), with Retail -18% (cc) and Biopharmaceuticals growing +7% (cc). Operating income.

Sales 40

Sales Medicine Production Manufacturing 40

The Pharma Data

JANUARY 13, 2021

(IPIX) is a clinical stage biopharmaceutical company developing a world-class portfolio of innovative therapies addressing multiple areas of unmet medical need, including inflammatory diseases, cancer, infectious diseases, and dermatologic diseases. Brilacidin for UP/UPS was licensed to Alfasigma S.p.A.

Clinical Trials 52

Clinical Trials Clinical Trials Trials In-Vitro 52